Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 599,743 | 555,146 | 512,495 | 566,616 | 441,909 |
| Cost of Goods | 49,577 | 51,858 | 39,626 | 32,939 | 51,552 |
| Gross Profit | 550,166 | 503,288 | 472,869 | 533,677 | 390,357 |
| Operating Expenses | 346,754 | 267,487 | 254,646 | 325,113 | 252,837 |
| Operating Income | 203,989 | 236,659 | 218,849 | 209,503 | 138,072 |
| Interest Expense | 567 | 655 | 715 | 1,063 | 807 |
| Other Income | 1,812 | 205 | 512 | 3,471 | 712 |
| Pre-tax Income | 205,234 | 236,209 | 218,646 | 211,911 | 137,977 |
| Income Tax | 51,814 | 58,478 | 52,151 | 52,557 | 156,969 |
| Net Income Continuous | 153,420 | 177,731 | 166,495 | 159,354 | -18,992 |
| Net Income | $153,420 | $177,731 | $166,495 | $159,354 | $-18,992 |
| EPS Basic Total Ops | 0.77 | 0.90 | 0.84 | 0.81 | -0.10 |
| EPS Basic Continuous Ops | 0.77 | 0.90 | 0.84 | 0.81 | -0.10 |
| EPS Diluted Total Ops | 0.76 | 0.88 | 0.83 | 0.79 | -0.09 |
| EPS Diluted Continuous Ops | 0.75 | 0.88 | 0.83 | 0.79 | -0.10 |
| EBITDA(a) | $219,016 | $249,963 | $232,611 | $226,410 | $182,703 |